Phosphodiesterase Inhibitor Medications: What Pharmacy Technicians Should Know
Learn about phosphodiesterase inhibitors, their classifications, common brand names, and key counseling points for the PTCB exam.
Understanding Phosphodiesterase Inhibitors
Phosphodiesterase (PDE) inhibitors are a class of medications that block one or more of the phosphodiesterase enzyme subtypes. These drugs play a role in treating conditions ranging from erectile dysfunction to pulmonary hypertension and chronic obstructive pulmonary disease (COPD).
Common PDE Inhibitor Subtypes
PDE-3 Inhibitors
Cilostazol (Pletal) is used for intermittent claudication. Milrinone is used in acute heart failure settings. These agents work by preventing platelet aggregation and promoting vasodilation.
PDE-4 Inhibitors
Roflumilast (Daliresp) and apremilast (Otezla) target inflammation. Roflumilast is approved for severe COPD, while apremilast treats psoriatic arthritis and plaque psoriasis.
PDE-5 Inhibitors
This is the most commonly tested subtype on the PTCB exam. Key medications include:
- Sildenafil (Viagra, Revatio)
- Tadalafil (Cialis, Adcirca)
- Vardenafil (Levitra)
- Avanafil (Stendra)
Important Counseling Points
PDE-5 inhibitors must never be combined with nitrates due to the risk of severe hypotension. Pharmacy technicians should flag potential interactions during prescription processing and alert the pharmacist immediately.
Sildenafil is unique because it is marketed under two brand names for two different indications: Viagra for erectile dysfunction and Revatio for pulmonary arterial hypertension.
Strengthen your medication knowledge with our PTCB flashcard deck and test yourself with a full practice exam.
Ready to ace the PTCE?
Practice with 800+ flashcards, 40 mini exams, and 10 full-length PTCE simulations.
Start Free